Public Health & Policy
Ebola Response: Slowed by a 'Perfect Storm' of Setbacks
WASHINGTON -- The world was taken by surprise by the West Africa Ebola outbreak and has been scrambling ever since to catch up, with many setbacks and only a few bright spots in the picture, international experts said at the Interscience Conference on Antimicrobial Agents and Chemotherapy.
Sep 08, 2014
Derms Want NP/PA Practice Limits
NPs and PAs who bill Medicaid as independent practitioners are more likely to bill for a dermatology visit than for any other office-based service -- so much so that in 2012, 55% of their Medicaid billings were for derm codes, to which dermatologists claim scope of practice violations.
Aug 15, 2014
FDA Panel Puts Brakes on Anti-PARP Drug
WASHINGTON -- Approval of a PARP inhibitor for patients with advanced ovarian cancer should await results of an ongoing clinical trial that has the potential to answer questions about the drug's safety and efficacy, according to an FDA advisory committee that voted against immediate approval.
Jun 25, 2014